Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study

Yukiya Narita, Hisato Kawakami, Koki Nakanishi, Akitaka Makiyama, Naotoshi Sugimoto, Hirotaka Konishi, Satoshi Morita, Keiko Minashi, Motohiro Imano, Rin Inamoto, Tomohiro Nishina, Takeshi Kawakami, Motohisa Hagiwara, Yasuhiro Kodera, Hiroki Kume, Keita Yamaguchi, Wataru Hashimoto, Kei Muro

Open source

DOI: 10.1093/jjco/hyaf216
Published: 2026-03-06
Container: Japanese Journal of Clinical Oncology
Publisher: Oxford University Press (OUP)
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/jjco/hyaf216,
  title = {Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study},
  author = {Yukiya Narita and Hisato Kawakami and Koki Nakanishi and Akitaka Makiyama and Naotoshi Sugimoto and Hirotaka Konishi and Satoshi Morita and Keiko Minashi and Motohiro Imano and Rin Inamoto and Tomohiro Nishina and Takeshi Kawakami and Motohisa Hagiwara and Yasuhiro Kodera and Hiroki Kume and Keita Yamaguchi and Wataru Hashimoto and Kei Muro},
  year = {2026},
  journal = {Japanese Journal of Clinical Oncology},
  doi = {10.1093/jjco/hyaf216},
  url = {https://doi.org/10.1093/jjco/hyaf216}
}

RIS

TY  - JOUR
TI  - Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study
AU  - Yukiya Narita
AU  - Hisato Kawakami
AU  - Koki Nakanishi
AU  - Akitaka Makiyama
AU  - Naotoshi Sugimoto
AU  - Hirotaka Konishi
AU  - Satoshi Morita
AU  - Keiko Minashi
AU  - Motohiro Imano
AU  - Rin Inamoto
AU  - Tomohiro Nishina
AU  - Takeshi Kawakami
AU  - Motohisa Hagiwara
AU  - Yasuhiro Kodera
AU  - Hiroki Kume
AU  - Keita Yamaguchi
AU  - Wataru Hashimoto
AU  - Kei Muro
PY  - 2026
JO  - Japanese Journal of Clinical Oncology
DO  - 10.1093/jjco/hyaf216
UR  - https://doi.org/10.1093/jjco/hyaf216
ER  -

APA

Narita, Y., Kawakami, H., Nakanishi, K., Makiyama, A., Sugimoto, N., Konishi, H., Morita, S., Minashi, K., Imano, M., Inamoto, R., Nishina, T., Kawakami, T., Hagiwara, M., Kodera, Y., Kume, H., Yamaguchi, K., Hashimoto, W., & Muro, K. (2026). Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study. Japanese Journal of Clinical Oncology. https://doi.org/10.1093/jjco/hyaf216

Source records

crossref · retrieved 2026-09-27T12:47:44.344Z